Bolt Biotherapeutics Funding & Investors
Bolt Biotherapeutics, Inc. operates as a biotechnology company. The Company develops immune-stimulating antibody conjugates, a new class of cancer therapeutics, which systemically-administered and uncover the immune system to induce anti-tumor immunity. Bolt Biotherapeutics serves healthcare industry in the United States.
boltbio.comTotal Amount Raised: $198,500,000
Bolt Biotherapeutics Funding Rounds
Series B
$54,000,000
Series B Investors
Nan Fung Life SciencesNovo HoldingsVivo CapitalPivotal bioVenture PartnersSeries Unknown
$9,999,998
Seed
$600,000
Post Ipo Equity
$15,000,000
Post Ipo Equity Investors
GenmabSeries C
$93,500,000
Series C Investors
Novo HoldingsVivo CapitalSofinnovaPfizer Venture InvestmentsRock Springs CapitalRA Capital ManagementSamsara BioCapitalPivotal bioVenture PartnersSurveyor CapitalSeries Unknown
$19,400,000
Series Unknown
$6,000,002
Funding info provided by Diffbot.